1887

Abstract

Human adenovirus (Ad) vectors are being used increasingly for a variety of applications in vaccination and gene therapy. The ability of vectors to enter cells and the efficiency of promoters expressing the therapeutic gene or vaccine antigen are critical to the outcome of such experiments. To identify promoters which might be suitable for use under a variety of conditions we have investigated the expression of a rotavirus antigen, VP7sc, employing several commonly used promoters carried in E1-substituted Ad vectors both in cell types which support virus replication and in cells which do not. Although not all gene constructions were identical, wide variations in promoter function were evident even in human 293 cells which support virus replication. The simian virus type 40 (SV40) early and β-actin promoters expressed poorly; the SV40 late promoter was somewhat better. The human IE94 cytomegalovirus (CMV) promoter and a modified Ad major late promoter were best, functioning equally well but with different kinetics. In other human cell lines the CMV promoter was more versatile, generally providing sustained expression at a significant level, in one case for at least 6 days. In addition, as mouse, rabbit and pig models of rotavirus infection are under investigation and VP7sc is a vaccine antigen, we also investigated the ability of the recombinant adenoviruses to infect cells from these and other sources. VP7sc expression was detected in several heterologous cell types, illustrating the ubiquity of the human Ad receptor and the versatility of human Ad as vectors when suitable promoters are used.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-8-1971
1995-08-01
2022-01-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/8/JV0760081971.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-8-1971&mimeType=html&fmt=ahah

References

  1. Anderson W. F. 1992; Human gene therapy. Science 256:808–813
    [Google Scholar]
  2. Andrew M. E., Boyle D. B., Whitfield P. L., Lockett L. J., Anthony I. D., Bellamy A. R., Both G. W. 1990; The immunogenicity of VP7, a rotavirus antigen resident in the ER, is enhanced by cell-surface expression. Journal of Virology 64:4776–4783
    [Google Scholar]
  3. Bacchetti S., Graham F. L. 1993; Inhibition of cell proliferation by an adenovirus vector expressing the human wild type-p53 protein. International Journal of Oncology 3:781–788
    [Google Scholar]
  4. Berkner K. L. 1988; Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6:616–629
    [Google Scholar]
  5. Both G. W., Lockett L. J., Janardhana V., Edwards S. J., Bellamy A. R., Graham F. L., Prevec L., Andrew M. E. 1993; Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193:940–950
    [Google Scholar]
  6. Boyle D. B., Pye A. D., Kockerhans R., Adair B. M., Vrati S., Both G. W. 1994; Characterisation of Australian ovine adenovirus isolates. Veterinary Microbiology 41:281–291
    [Google Scholar]
  7. Chanda P. K., Natuk R. J., Mason B. B., Bhat B. M., Greenberg L., Dheer S., Molnar-Kimber K. L., Mizutani S., Lubeck M. D., Davis A. R., Hung P. P. 1990; High level expression of the envelope glycoproteins of the human immunodeficiency virus type 1 in the presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 175:535–547
    [Google Scholar]
  8. Conner M. E., Crawford S. E., Barone C., Estes M. K. 1993; Rotavirus vaccine administered parenterally induces protective immunity. Journal of Virology 67:6633–6641
    [Google Scholar]
  9. Conner M. E., Matson D. O., Estes M. K. 1994; Rotavirus vaccines and vaccination potential. Current Topics in Microbiology and Immunology 185:286–337
    [Google Scholar]
  10. Couch R. B., Chanock R. M., Cate T. R., Lang D. J., Knight V., Heubner R. J. 1963; Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. American Review of Respiratory Disease 88:394–403
    [Google Scholar]
  11. Davidson D., Hassell J. A. 1987; Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector. Journal of Virology 61:1226–1239
    [Google Scholar]
  12. Ginsberg H. S., Lundholm-Beauchamp U., Horswood R. L., Pernis B., Wold W. S. M., Chanock R. M., Prince G. A. 1989; Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proceedings of the National Academy of Sciences USA 86:3823–3827
    [Google Scholar]
  13. Gluzman Y. 1981; SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175–182
    [Google Scholar]
  14. Gooding L. R. 1992; Virus proteins that counteract host immune defenses. Cell 71:5–7
    [Google Scholar]
  15. Graham F. L., Prevec L. 1991; Manipulation of adenovirus vectors. In Methods in Molecular Biology pp 1–19 Edited by Murray E. J., Walker J. M. Clifton, New Jersey: Humana Press;
    [Google Scholar]
  16. Graham F. L., van der Eb A. J. 1973; A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–467
    [Google Scholar]
  17. Graham F. L., Prevec L. 1992; Adenovirus based expression vectors and recombinant vaccines. In Vaccines: New Approaches to Immunological Problems pp 363–390 Edited by Elliss W. R. Stoneham, Mass: Butterworth-Heinemann;
    [Google Scholar]
  18. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
  19. Gunning P., Leavitt J., Muscat G., Ng S.-Y., Redes L. 1987; A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proceedings of the National Academy of Sciences USA 84:4831–4835
    [Google Scholar]
  20. Hitt M., Bett A., Addison C., Prevec L., Graham F. L. (In Press) Human adenovirus vector construction and characterisation. Methods in Molecular Genetics
    [Google Scholar]
  21. Horwitz M. S. 1990; Adenoviruses. In Virology pp 1723–1740 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  22. Jacobs S. C., Stephenson J. R., Wilkinson G. W. G. 1992; High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector-protection elicited in a murine model. Journal of Virology 66:2086–095
    [Google Scholar]
  23. Johnson D. C., Ghosh-Choudhury G., Smiley J. R., Fallis L., Graham F. L. 1988; Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164:1–14
    [Google Scholar]
  24. Kapikian A. Z., Chanock R. M. 1990; Rotaviruses. In Virology pp 1353–1404 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  25. Levrero M., Barban V., Manteca S., Ballay A., Balsamo C., Avantaggiati M. L., Natoli G., Skellekens H., Tiollais P., Perricaijdet M. 1991; Defective and nondefective adenovirus vectors for expressing foreign genes in-vitro and in-vivo. GENE (Amsterdam) 101:195–202
    [Google Scholar]
  26. Lewis A. M., Levine A. S., Crumpacker C. S., Levin M. J., Samaha R. J., Henry P. H. 1973; Studies of non-defective adenovirus 2-SV40 specific biological properties. Journal of Virology 11:655–664
    [Google Scholar]
  27. Liu F., Green M. R. 1994; Promoter targeting by adenovirus-Ela through interaction with different cellular DNA-binding domains. Nature 368:520–525
    [Google Scholar]
  28. Mason B. B., Davis A. R., Bhat B. M., Chengalvala M., Lubeck M. D., Zandle G., Kostek B., Cholodofsky S., Dheer S., Molnar-Kimber K., Mizutani S., Hung P. P. 1990; Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron. Virology 177:452–461
    [Google Scholar]
  29. McGrory W. J., Bautista D. S., Graham F. L. 1988; A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163:614–617
    [Google Scholar]
  30. Mittal S. K., McDermott M. R., Johnson D. D., Prevec L., Graham F. L. 1993; Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Research 28:67–90
    [Google Scholar]
  31. Morgenstern J. P., Land H. 1990; A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Research 18:1068
    [Google Scholar]
  32. Morin J. E., Lubeck M. D., Barton J. E., Conley A. J., Davis A. R., Hung P. P. 1987; Recombinant adenovirus induces antibody responses to hepatitis B virus surface antigen in hamsters. Proceedings of the National Academy of Sciences USA 84:4626–4630
    [Google Scholar]
  33. Morsy M. A., Alford E. L., Bett A., Graham F. L., Caskey C. T. 1993; Efficient adenoviral vector mediated ornithine trans-carbamylase expression in deficient mouse and human hepatocytes. Journal of Clinical Investigation 92:1580–1586
    [Google Scholar]
  34. Mulligan R. C. 1993; The basic science of gene therapy. Science 260:926–932
    [Google Scholar]
  35. Offit P. A. 1994; Rotaviruses: immunologic determinants of protection against infection and disease. Advances in Virus Research 44:161–202
    [Google Scholar]
  36. Schaller J. P., Saif L. J., Cordle C. T., Candler E., Winship T. R., Smith K. L. 1992; Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. Journal of Infectious Diseases 165:623–630
    [Google Scholar]
  37. Schneider M., Graham F. L., Prevec L. 1989; Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. Journal of General Virology 70:417–427
    [Google Scholar]
  38. Spessot R., Inchley K., Hupel T. M., Bacchetti S. 1989; Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. Virology 168:378–387
    [Google Scholar]
  39. Sprague J., Condra J. H., Arnheiter H., Lazzarini R. A. 1983; Expression of a recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein. Journal of Virology 43:369–378
    [Google Scholar]
  40. Top F. H. Jr, Buescher E. L., Bancroft W. H., Russell P. K. 1971; Immunization with live types 4 and 7 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. Journal of Infectious Diseases 124:155–160
    [Google Scholar]
  41. Ward R. L., McNeal M. M., Sheridan J. F. 1990; Development of an adult mouse model for studies on protection in rotavirus. Journal of Virology 64:5070–5075
    [Google Scholar]
  42. Wold W. S. M., Gooding L. R. 1991; Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1–8
    [Google Scholar]
  43. York I. A., Roop C., Andrews D. W., Riddell S. R., Graham F. L., Johnson D. C. 1994; A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8 (+) T lymphocytes. Cell 77:525–535
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-8-1971
Loading
/content/journal/jgv/10.1099/0022-1317-76-8-1971
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error